These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 22757655

  • 1. Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgia.
    Jensen MP, Hsu PH, Vanhove GF.
    Pain Med; 2012 Aug; 13(8):1059-66. PubMed ID: 22757655
    [Abstract] [Full Text] [Related]

  • 2. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Rauck RL, Irving GA, Wallace MS, Vanhove GF, Sweeney M.
    J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
    [Abstract] [Full Text] [Related]

  • 3. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
    Sang CN, Sathyanarayana R, Sweeney M, DM-1796 Study Investigators.
    Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.
    Jensen MP, Irving G, Rauck R, Wallace M, Sweeney M, Vanhove GF.
    Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
    Irving G, Jensen M, Cramer M, Wu J, Chiang YK, Tark M, Wallace M.
    Clin J Pain; 2009 Sep; 25(3):185-92. PubMed ID: 19333167
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.
    Gupta A, Li S.
    Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280
    [Abstract] [Full Text] [Related]

  • 8. Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia.
    Jensen MP, Chiang YK, Wu J.
    Clin J Pain; 2009 May; 25(4):286-92. PubMed ID: 19590476
    [Abstract] [Full Text] [Related]

  • 9. Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin: Interaction of Patient Demographics, Disease Characteristics, and Efficacy Outcomes.
    Kantor D, Panchal S, Patel V, Bucior I, Rauck R.
    J Pain; 2015 Dec; 16(12):1300-1311. PubMed ID: 26409117
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia.
    Chen C, Han CH, Sweeney M, Cowles VE.
    J Pharm Sci; 2013 Apr; 102(4):1155-64. PubMed ID: 23381946
    [Abstract] [Full Text] [Related]

  • 11. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
    Wallace MS, Irving G, Cowles VE.
    Clin Drug Investig; 2010 Apr; 30(11):765-76. PubMed ID: 20818838
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
    Backonja MM, Canafax DM, Cundy KC.
    Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
    [Abstract] [Full Text] [Related]

  • 13. The intestinal absorption mechanism of gabapentin makes it appropriate for gastroretentive delivery.
    Chen C, Cowles VE, Sweeney M.
    Curr Clin Pharmacol; 2013 Feb 01; 8(1):67-72. PubMed ID: 22946876
    [Abstract] [Full Text] [Related]

  • 14. Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials.
    Wang J, Zhu Y.
    J Dermatolog Treat; 2017 Feb 01; 28(1):65-77. PubMed ID: 27798973
    [Abstract] [Full Text] [Related]

  • 15. Clinical development of a once-daily gastroretentive formulation of gabapentin for treatment of postherpetic neuralgia: an overview.
    Argoff CE, Chen C, Cowles VE.
    Expert Opin Drug Deliv; 2012 Sep 01; 9(9):1147-60. PubMed ID: 22809245
    [Abstract] [Full Text] [Related]

  • 16. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M, Sadosky A, Tai KS, Stacey B.
    Clin Ther; 2007 Aug 01; 29(8):1655-70. PubMed ID: 17919547
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
    Ifuku M, Iseki M, Hidaka I, Morita Y, Komatus S, Inada E.
    Pain Med; 2011 Jul 01; 12(7):1112-6. PubMed ID: 21692969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.